Elevated CCN1/CYR61 levels is associated with poor prognosis for various cancers including breast cancer [4,5], prostate cancer [6,7], gastric cancer [8], oral squamous cell carcinoma [9], lung cancer [10,11,12], and hepatocellular carcinoma [13]. This evidence concerns the gene CCN1 and prostate cancer.